Skip to content
  • Home
  • About Us
  • What We Do
  • Pipeline
  • Indications
  • Publication
  • Contact us
Menu
  • Home
  • About Us
  • What We Do
  • Pipeline
  • Indications
  • Publication
  • Contact us

slider1 ABOUT US Developing allogeneic CAR-T cells
for refractory diseases Repairing and controlling genes in cells or replacing missing or damaged cells can solve the underlying cause of many diseases. These emerging capabilities will create novel medicines that meaningfully improve patient outcomes, and T-MAXIMUM aims to lead the way.

Read More slider2 WHAT WE DO Addressing challenges in engineered
T cell therapies We are acutely aware of the challenges facing engineered T cell therapies, including safety concerns, the complexity of treatment, and accessibility. Our team is committed to advancing the field with unique strategies.
Read More slider2 OUR VISION Realizing full potential of engineered
T cell therapies We believe in a future where the full therapeutic potential of engineered T cells is realized, offering personalized, effective, and accessible treatments for a wide range of diseases. Our dedication to innovation, safety, and patient care guides our journey towards revolutionizing medicine and improving lives around the globe.
Read More